RSLS
ReShape Lifesciences Inc.
3.92
undefined x undefined
undefined x undefined
bid
ask
+
0.72
22.50%
04:00 PM
| Ytd | -99.12% | |
| 1y | -99.62% |
2.80
day range
4.65
4.09
52 week range
29.00
| Open | 3.06 | Prev Close | 3.20 | Low | 2.80 | High | 4.65 | Mkt Cap | 3.04M |
| Vol | 13.59M | Avg Vol | 113.58K | EPS | 77.26 | P/E | 0.06 | Forward P/E | -11.83 |
| Beta | 1.35 | Short Ratio | 0.22 | Inst. Own | 1.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 5.39 | 200-d Avg | 9.00 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 1.24M | ||
| Revenues (USD) | 1.24M | ||
| Cost of Revenue | 643.00K | ||
| Gross Profit | 599.00K | ||
| Operating Expenses | 3.36M | ||
| Research and Development Expense | 476.00K | ||
| Selling, General and Administrative Expense | 2.17M | ||
| Operating Income | -2.76M | ||
| Interest Expense | -18.00K | ||
| Income Tax Expense | 8.00K | ||
| Net Income | -2.63M | ||
| Net Income Common Stock | -2.63M | ||
| Net Income Common Stock (USD) | -2.63M | ||
| Consolidated Income | -2.63M | ||
| Earnings per Basic Share | -2.25 | ||
| Earnings per Basic Share (USD) | -2.25 | ||
| Earnings per Diluted Share | -2.25 | ||
| Earning Before Interest & Taxes (EBIT) | -2.64M | ||
| Earning Before Interest & Taxes (USD) | -2.64M | ||
| Weighted Average Shares | 1.17M | ||
| Weighted Average Shares Diluted | 1.17M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.22M | ||
| Cash and Equivalents (USD) | 4.22M | ||
| Investments | 605.00K | ||
| Investments Current | 605.00K | ||
| Trade and Non-Trade Receivables | 775.00K | ||
| Current Assets | 8.86M | ||
| Property, Plant & Equipment Net | 109.00K | ||
| Total Assets | 9.03M | ||
| Debt Current | 104.00K | ||
| Total Debt | 104.00K | ||
| Current Liabilities | 3.20M | ||
| Total Liabilities | 3.20M | ||
| Accumulated Retained Earnings (Deficit) | -643.86M | ||
| Accumulated Other Comprehensive Income | -109.00K | ||
| Shareholders Equity | 5.83M | ||
| Shareholders Equity (USD) | 5.83M | ||
| Assets Non-Current | 166.00K | ||
| Total Debt (USD) | 104.00K | ||
| Inventory | 2.55M | ||
| Trade and Non-Trade Payables | 1.35M | ||
| Tax Assets | 28.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.00K | ||
| Net Cash Flow from Financing | 6.10M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.61M | ||
| Issuance (Purchase) of Equity Shares | 6.10M | ||
| Net Cash Flow from Operations | -4.49M | ||
| Effect of Exchange Rate Changes on Cash | 1000 | ||
| Share Based Compensation | 12.00K | ||